Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Revenue | 663M | 585M | 500M | 392M | 348M | 281M |
| Cost of revenue | 56M | 53M | 46M | 37M | 35M | 30M |
| Research and development | 207M | 196M | 197M | 191M | 167M | 143M |
| Selling, general and administrative | 66M | 69M | 69M | 69M | 66M | 68M |
| Operating expenses | 480M | 446M | 432M | 388M | 341M | 312M |
| Operating income | 183M | 139M | 68M | 4M | 7M | −31M |
| Pre-tax income | 206M | 161M | 89M | 24M | 30M | −10M |
| Income tax | 2M | −2M | −439,000 | −2M | −31,000 | −216,000 |
| Net income | 204M | 163M | 89M | 26M | 30M | −10M |
| Earnings per share | 1.07 | 0.87 | 0.48 | 0.14 | 0.18 | −0.06 |
| Earnings per share, diluted | 1.01 | 0.80 | 0.45 | 0.13 | 0.16 | −0.06 |
| Weighted average shares | 192M | 188M | 185M | 182M | 169M | 164M |
| Weighted average shares, diluted | 203M | 203M | 200M | 201M | 192M | 164M |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1.37B | 954M | 912M | 734M | 636M | 562M | 516M | 468M |
| Receivables | 523M | 590M | 488M |
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | 312M | 185M | 111M | 128M | 72M | 28M |
| Depreciation and amortisation | 4M | 4M | 4M | 4M | 4M | 4M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 407M |
| 326M |
| 350M |
| 284M |
| 240M |
| Current assets | 3.39B | 3.14B | 2.77B | 2.53B | 2.33B | 2.22B | 2.06B | 1.98B |
| Property, plant and equipment | 12M | 13M | 13M | 11M | 12M | 13M | 14M | 14M |
| Goodwill | 42M | 42M | 42M | 42M | 42M | 42M | 42M | 26M |
| Total assets | 3.48B | 3.24B | 2.88B | 2.63B | 2.44B | 2.34B | 2.17B | 2.08B |
| Current liabilities | 266M | 271M | 228M | 211M | 187M | 176M | 172M | 160M |
| Total liabilities | 305M | 310M | 266M | 245M | 220M | 206M | 194M | 183M |
| Equity | 3.18B | 2.93B | 2.61B | 2.39B | 2.22B | 2.13B | 1.98B | 1.89B |
| Share-based compensation | 68M | 84M | 89M | 85M | 75M | 64M |
| Capital expenditure | 1M | 2M | 505,000 | 979,000 | 1M | 1M |
| Investing cash flow | 125M | 17M | −2M | −28M | 8M | −520M |
| Share buybacks | 5M | — | — | 0 | — | — |
| Financing cash flow | −16M | −24M | −11M | −26M | −32M | −9M |